|
Match
|
Document |
Document Title |
|
|
5686491 |
Infant formula
The present invention provides an infant formula for infants with metabolic disorders in fatty acid catabolism such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD), long-chain acyl-CoA...
|
|
|
5672590 |
Pharmaceutical composition for immunomodulating and adjuvant treatment
Pharmaceutical composition for immunomodulating and adjuvant therapy containing a metabolic stressor, 2-deoxy-D-ribose and further active components, i.e. ribose, DL-alanine, nicotonic acid,...
|
|
|
5670539 |
Treatment of movement disorders using large neutral amino acids
The present invention relates to a method of remitting or attenuating the symptoms of movement disorders which can be secondary to treatment of psychiatric disorders with antipsychotic drugs mainly...
|
|
|
5665371 |
Medicines which contain derivatives of proline or hydroxyproline
Pharmaceutical compositions which comprise, as an active substance, (N-alkyl) derivatives of proline or hydroxyproline. Such compositions are useful in the treatment of cancer.
|
|
|
5663208 |
Antifungal wound healing compositions and methods for preparing and using same
This invention pertains to therapeutic antifungal-wound healing compositions. The compositions comprise a therapeutically effective amount of an antifungal agent and a wound healing compositions....
|
|
|
5663203 |
Agents containing prostacyclin derivatives for topical application
The invention relates to a dermal application form of prostacyclin derivatives of Formula I ##STR1## wherein R1 means hydrogen or alkyl of 1-10 carbon atoms,A is a --CH2 --CH2 --, trans-CHCH-- o...
|
|
|
5658957 |
Immunostimulating wound healing compositions and method for preparing and using same
This invention pertains to therapeutic immunostimulating-wound healing compositions. The compositions comprise a therapeutically effective amount of an immunostimulating agent and a wound healing...
|
|
|
5656668 |
Hydroxy alkyl amides of dicarboxylic acids and their use in cosmetic compositions
A class of pseudoceramide having the formula shown in which: R1 is a hydrocarbon group; R2-R8 are each independently H or CH3 ; R9 and R10 are each independently H or hydrocarbon group of up to 24...
|
|
|
5654278 |
Composition and method comprising growth hormone and leucine
A pharmaceutical formulation comprising a growth hormone and leucine shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows...
|
|
|
5650390 |
Gonadotropin containing pharmaceutical compositions with sucrose stabilizer
Pharmaceutical compositions containing FSH, LH or hCG stabilized by means of a combination of sucrose and glycine. The formulation is particularly suitable for stabilizing a lyophilisate of...
|
|
|
5650172 |
Pharmaceutical preparation comprising fat emulsion of fat microparticles
A preparation comprising a fat emulsion of fat microparticles wherein said emulsion contains a stabilizer consisting essentially of a fatty acid, a basic amino acid and a saccharide is provided. In...
|
|
|
5650149 |
Cosmetic composition for proliferating indigenous bacteria on skin
A cosmetic composition containing triglyceride oleate and yeast extract and further, if desired, an L-cysteine hydrochloride as components for proliferating indigenous bacteria on the skin.
|
|
|
5646187 |
Use of alpha-ketoglutarate
The invention relates to the use of alpha-ketoglutarate or analogues thereof in the preparation of a medicament for treatment of critically ill patients for improving protein synthesis capacity,...
|
|
|
5646182 |
Methods for treating autoimmune diseases
The present invention provides methods for treating autoimmune disease in humans by administering to an afflicted host pharmaceutical compositions containing a therapeutically effective amount of a...
|
|
|
5645849 |
Hemostatic patch
A fibrogen-free substrate having as a hemostatic agent on a surface thereof a mixture of a clot-promoting amount of thrombin and an amount of epsilon aminocaproic acid (EACA) effective to...
|
|
|
5643954 |
Method of preventing and alleviating stress in a healthy mammal in need thereof
A pharmaceutical preparation of antistress, stress-protective and nootropic effect contains an effective substance represented by an amino-acid glycine or its pharmaceutically acceptable salt.A...
|
|
|
5635535 |
Method for increasing blood glucose levels
A method of increasing blood glucose levels while metabolizing body fat. The method includes the steps of subjecting the individual to conditions where they start to use body fat as an energy...
|
|
|
5635213 |
Pharmaceutical formulation
A pharmaceutical formulation for intraduodenal administration comprising at least one phamacologically active agent, with limited solubility in water and is dispersed in an aqueous carrier....
|
|
|
5629321 |
Bicyclic compound and platelet aggregation inhibitor containing the same
The invention relates to a novel compound which is represented by the formula (1) and has an excellent platelet aggregation inhibiting action based on fibrinogen antagonism. The platelet...
|
|
|
5626883 |
Ascorbic acid compositions providing enhanced human immune system activity
A vitamin C supplement comprising ascorbic acid, ascorbyl palmitate, niacinamide ascorbate, calcium ascorbate, magnesium ascorbate, potassium ascorbate, and sodium ascorbate which together can be...
|
|
|
5622981 |
Use of metabotropic receptor agonists in progressive neurodegenerative diseases
A method of treating a mammal with a neurodegenerative disease which is caused at least in part by the neurotoxic effects of the β-amyloid protein. This method constitutes administering a ...
|
|
|
5622916 |
Substituted 2-cylcohexen-1-yl-amine fungicidal and herbicidal agents
A method of combating pests which comprises applying to such pests or to a pest habitat a pesticidally effective amount of a substituted 2-cyclohexen-1-yl-amine derivative of the formula ##STR1##...
|
|
|
5621008 |
N-acyl-ethylene-triacetic acids
Disclosed is the novel use of N-acyl-N,N',N'-ethylenediaminetriacetic acids and N-acyl-N,N',N'-(ethylenedioxy) diethylenedinitrilotriacetic acids as active ingredients in preventative as well as...
|
|
|
5616617 |
Face pimples prevention method and compositions
Disclosed is the method of determining the effectiveness of an agent for the prevention of facial pimples or acne, comprising the steps of a) administering to a susceptible subject a quantity of a...
|
|
|
5614557 |
Method of controlling tumor growth rate
α-Fluoromethyl- or α-difluoromethylornithine, and certain derivatives thereof, can be used alone or in combination with cytotoxic agents for the treatment of neoplastic diseases.
|
|
|
5614224 |
Nutritional supplement for diabetics
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose are disclosed. The supplement includes sources of vanadate and chromium as well as L-carnitine.
|
|
|
5607973 |
Method of treating traumatic CNS tissue injury with a metabotropic glutamate receptor agonist
A method for in vivo reducing the deleterious effect of traumatic CNS tissue injury by applying to said tissue a therapeutically effective amount of a metabotropic glutamate receptor agonist,...
|
|
|
5602174 |
Treatment
A method of treatment or prophylaxis of angina in mammals, such as humans, which comprises the administration to the sufferer of an effective amount of a compound of formula (I), or a...
|
|
|
5602150 |
Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
The present invention relates to a method of treatment and a composition used to prevent the development of the adverse manifestation of tardive dyskinesia in individuals suffering from mental...
|
|
|
5587399 |
Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
The present invention involves a method of preparing a nutritional product in which a powder base containing fats, carbohydrates, vitamins, minerals and trace elements is mixed with specific amino...
|
|
|
5587169 |
Cosmetic or pharmaceutical composition comprising an alkyl carbamate as hydrating agent
The invention relates to a cosmetic or pharmaceutical composition comprising as hydrating agent a compound of the alkyl N-(hydroxyalkyl)carbamate family.
|
|
|
5583101 |
Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
A method for inhibiting or relaxing skeletal muscle contractions which comprises contacting said skeletal muscle with a skeletal muscle relaxing amount, and a method for the treatment of disease...
|
|
|
5580903 |
Liver regeneration accelerator
A method of treating a patient in need of stimulation of hepatocyte mitosis which comprises administering to said patient an effective amount of alanine and/or glutamine.
|
|
|
5578645 |
Methods and compositions for treating acute or chronic pain and drug addiction
Methods and compositions for treating acute or chronic pain in a mammal comprising administering a therapeutically effective amount of an analgesic solution comprising at least one branched chain...
|
|
|
5576355 |
Diamondoid derivatives for pharmaceutical use
A method of inhibiting viruses in which a virus is contacted with diamondoid alcohol, ketone, ketone derivative, adamantyl amino acid, quaternary salt or combinations thereof which have antiviral...
|
|
|
5576287 |
Method for treating acute renal disease and failure
A nutritional composition and methods of using same for treating and preventing renal failure is provided. The nutritional composition includes a therapeutically effective amount of a source...
|
|
|
5576316 |
Method for inhibiting tumor growth rate using creatine or creatine analogs
A method for inhibiting tumor growth rate using creatine or creatine analogs is described. The creatine or creatine analogs are administered to subjects such that tumor growth rate is inhibited....
|
|
|
5571839 |
D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infectious diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumors.
|
|
|
5567731 |
Gaba-ergic modulation of eye growth
A composition for the inhibition of the abnormal postnatal axial growth of the eye of a maturing animal which comprises a pharmaceutically effective amount of a gamma aminobutyric acid antagonist...
|
|
|
5567410 |
Composotions and methods for radiographic imaging
A radiographic imaging agent including a plurality of block copolymers forming a micelle, the block copolymers including a hydrophilic polymer linked to a hydrophobic polymer, and the hydrophobic...
|
|
|
5565493 |
Collagen metabolism ameliorant and its use in the stimulation of hair growth
This invention relates to a collagen metabolism ameliorant containing N-methyl-L-serine as an active ingredient, more particularly, a collagen metabolism ameliorant efficacious against collagen...
|
|
|
5559142 |
Amino acid supplementation of dietary proteins
A universal dietary supplement for proteins consisting of a blend of four essential amino acids was developed. A unit dose consisting of a blend of 80 mg of L-Tryptophan, 90 mg of L-Methionine, 103...
|
|
|
5554618 |
Intravenously administrable aqueous solution
An intravenously administrable, aqueous solution of a water-soluble, physiologically tolerable salt of sulfametrole and of trimethoprim, in which malic acid, L-serine and/or L-threonine are present...
|
|
|
5550146 |
Medical foods for the nutritional support of infant/toddler metabolic diseases
The present invention relates generally to a generic powder base rich in fats, carbohydrates, vitamins and minerals and trace elements which can be readily admixed with specific amino acids to...
|
|
|
5550110 |
Endothelin Antagonists II
Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute...
|
|
|
5547680 |
Method for preparing a topical, aminocaproic acid containing ophthalmic gel
A topical gel formulation containing aminocaproic acid prevents secondary hemorrhage following hyphema without the adverse side effects associated with systemically delivered aminocaproic acid. Of...
|
|
|
5541226 |
Topical compositions for re-epithelialization of persistent epithelial defects
Persistent epithelial defects are effectively treated by topically applying a gelatinous composition containing either aminocaproic acid or tranexamic acid to the eye. In vivo results demonstrate...
|
|
|
5534545 |
Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production
An anti-hypotensive formulation comprising an essentially arginine-free or low arginine (less than about 0.1%, most preferably, about 0.01%) containing mixture of amino acids is provided. The...
|
|
|
5523323 |
Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
This invention concerns inhibitors of the tolerance and dependence induced by opiate analgesics. Excitatory amino acids control the action of the NMDA receptor through allosteric binding sites....
|
|
|
5520905 |
Cosmetic or dermatological preparation comprising delta-aminolevulinic acid content as an active ingredient
A cosmetic or dermatological preparation comprising δ-aminolevulinic acid as an active ingredient.
|